| Announce Date | 08/01/2025 |
| EPS Normalized Actual | $-0.01001 (Miss by $-0.03001) |
| EPS GAAP Actual | $-0.01001 (Miss by $-0.03001) |
| Revenue Actual | $0.044012B |
| Revenue Surprise | Beat by $44.012M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.135 |
| EPS GAAP Estimate | $0.135 |
| Revenue Estimate | $0.059628667B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0.04 | 152.75 | 0.03857985 | 0.04194563 | 1 |
| Dec 2027 | 0.59 | 10.36 | 0.56897 | 0.61715 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.01 | -0.215 | 0.044012B | -15.89% | -26.85M |
| FQ1 2025 (Mar 2025) | -0.05 | -0.05 | 0.039371B | -20.95% | 39.37M |
| FQ4 2024 (Dec 2024) | -0.0873 | -0.0873 | 0.039178B | -21.52% | 39.18M |
| FQ3 2024 (Sep 2024) | -0.1 | -0.1 | 0.042548B | -9.98% | 42.55M |
| FQ2 2024 (Jun 2024) | -0.0557 | -0.0557 | 0.051004B | -9.21% | 51M |
| FQ1 2020 (Mar 2020) | 0 | 0 | 0.011043B | 100% | 11.04M |
| FQ2 2020 (Jun 2020) | 0 | 0 | 0.011043B | 100% | 11.04M |
| FQ1 2024 (Mar 2024) | 0.11 | 0.11 | 0.04762B | 3.79% | 47.62M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.135
Consensus Revenue Estimates
0.059628667B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.13 | -- | 0.13 | 0.13 | 1 |
| FQ3 2027 (Sep 2027) | 0.12 | -- | 0.12 | 0.12 | 1 |
| FQ2 2027 (Jun 2027) | 0.2 | -- | 0.2 | 0.2 | 1 |
| FQ1 2027 (Mar 2027) | 0.14 | -- | 0.14 | 0.14 | 1 |
| FQ4 2026 (Oct 2026) | 0.13 | -- | 0.12563 | 0.13571 | 0 |
| FQ3 2026 (Jul 2026) | 0.19 | -- | 0.18361 | 0.19834 | 0 |
| FQ2 2026 (Jun 2026) | 0.195 | 105.13 | 0.195 | 0.195 | 0 |
| FQ1 2026 (Mar 2026) | 0.135 | 137.04 | 0.135 | 0.135 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.06B | -- | 0.06B | 0.06B | 1 |
| FQ3 2027 (Sep 2027) | 0.06B | -- | 0.06B | 0.06B | 1 |
| FQ2 2027 (Jun 2027) | 0.07B | -- | 0.07B | 0.07B | 1 |
| FQ1 2027 (Mar 2027) | 0.06B | -- | 0.06B | 0.06B | 1 |
| FQ4 2026 (Oct 2026) | 0.06B | -- | 0.06B | 0.07B | 1 |
| FQ3 2026 (Jul 2026) | 0.07B | -- | 0.07B | 0.08B | 1 |
| FQ2 2026 (Jun 2026) | 0.07B | 39.65 | 0.07B | 0.07B | 1 |
| FQ1 2026 (Mar 2026) | 0.06B | 36.29 | 0.06B | 0.06B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
5
EPS # of in-lines
2
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.205 | -0.01 | -0.215 | 2150% |
| FQ1 2025 (Mar 2025) | -0.05 | -0.05 | 100% | |
| FQ4 2024 (Dec 2024) | -0.0873 | -0.0873 | 100% | |
| FQ3 2024 (Sep 2024) | -0.1 | -0.1 | 100% | |
| FQ2 2024 (Jun 2024) | -0.0557 | -0.0557 | 100% | |
| FQ1 2020 (Mar 2020) | 0 | 0 | NAN% | |
| FQ2 2020 (Jun 2020) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 0.11 | 0.11 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.07B | $0.04B | $-26.85M | -61.01% |
| FQ1 2025 (Mar 2025) | $0B | $0.04B | $39.37M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.04B | $39.18M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.04B | $42.55M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.05B | $51M | 100% |
| FQ1 2020 (Mar 2020) | $0B | $0.01B | $11.04M | 100% |
| FQ2 2020 (Jun 2020) | $0B | $0.01B | $11.04M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.05B | $47.62M | 100% |